US Patent Issued to Roche Diagnostics Operations on July 21 for "Method for determining glycated hemoglobin a (HbA1C) by mass spectrometry" (German Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,687,551, issued on July 21, was assigned to Roche Diagnostics Operations Inc. (Indianapolis).

"Method for determining glycated hemoglobin a (HbA1C) by mass spectrometry" was invented by Uwe Kobold (Weilheim, Germany), Andreas Leinenbach (Oberhausen, Germany) and Indranil Mitra (Munich Sud, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention refers to a method for determining peptide fragments of glycated hemoglobin A (HbA1c) molecules by mass spectrometry (MS), a reagent kit, and a clinical diagnostic system adapted for performing the method."

The patent was filed on July 8, 2021, under Application No. 17/370,170.

*For further...